Specialty Generics Market Report

The global specialty generics market reached a value of US$ 44.8 Billion in 2018. Specialty generics are generic versions of specialty drugs, once they get off-patent. These drugs are used to treat chronic or complex health conditions including cancer, autoimmune diseases, epilepsy, HIV, Hepatitis, multiple sclerosis, rheumatoid arthritis, etc. Speciality generics are cost-effective as compared to their branded versions as they don’t require costly development and marketing costs.

Compared to traditional generics, the speciality generics market is more concentrated with fewer players due to their complex manufacturing requirements, higher capital costs and relatively lower volumes as a result of smaller patient population. This results in lower price reduction compared to the branded drug and consequently higher margins compared to traditional generics. Speciality generics require special handling, administration, monitoring and generally need prior authorization to order them. The global speciality generics market is currently being driven by several factors such as rising ageing population, patent expiration of a number of branded specialty drugs, increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, HIV, etc., cost containment measures from healthcare providers, growth from emerging markets, etc.  Looking forward, the market value is further expected to reach US$ 88.9 Billion by 2024, exhibiting a CAGR of 11.9% during 2019-2024.

IMARC Group’s latest report provides a deep insight into the global specialty generics market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global smart lighting market in any manner.

Report Scope:

Historical, Current and Future Market Trends

Market Breakup by Region:

• North America
  • United States
  • Canada
• Europe
  • Italy
  • Germany
  • Spain
  • United Kingdom
  • France
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa

Market Breakup by Route of Administration:

• Injectables
• Oral
• Others

Market Breakup by Indication:

• Oncology
• Autoimmune Diseases
• Infectious Diseases
• Others

Market Breakup by Distribution channel:

• Retail Pharmacies
• Specialty Pharmacies
• Hospital Pharmacies

Competitive Landscape:

The global specialty generics market consists of numerous manufacturers. Some of the leading players operating in the market are Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Apotex Corp., Endo International plc.

Key Questions Answered in This Report:

• How has the global specialty generics market performed so far and how will it perform in the coming years?
• What are the key regional markets in the global specialty generics industry?
• What is the breakup of the global specialty generics market based on the indication?
• What is the breakup of the global specialty generics market based on the route of administration?
• What is the breakup of the global specialty generics market based on the distribution channel?
• What are the various stages in the value chain of the global specialty generics industry?
• What are the key driving factors and challenges in the global specialty generics market?
• What is the structure of the global specialty generics industry and who are the key players?
• What is the degree of competition in the global specialty generics market?

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Global Specialty Generics Market: Introduction
5    Why are Specialty Generics So Lucrative?
6    Global Specialty Generics Market
    6.1    Market Overview
    6.2    Market Performance
    6.3    Market Breakup by Route of Administration
    6.4    Market Breakup by Indication
    6.5    Market Breakup by Distribution Channel
    6.6    Market Breakup by Region
    6.7    Market Forecast
    6.8    SWOT Analysis
        6.8.1    Overview
        6.8.2    Strengths
        6.8.3    Weaknesses
        6.8.4    Opportunities
        6.8.5    Threats
    6.9    Value Chain Analysis
    6.10    Porters Five Forces Analysis
        6.10.1    Overview
        6.10.2    Bargaining Power of Buyers
        6.10.3    Bargaining Power of Suppliers
        6.10.4    Degree of Competition
        6.10.5    Threat of New Entrants
        6.10.6    Threat of Substitutes
    6.11    Key Market Drivers and Success Factors
7    Market Breakup by Route of Administration
    7.1    Injectable
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Oral
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Others
        7.3.1    Market Trends
        7.3.2    Market Forecast
8    Market Breakup by Indication
    8.1    Oncology
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Autoimmune Diseases
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Infectious Diseases
        8.3.1    Market Trends
        8.3.2    Market Forecast
    8.4    Others
        8.4.1    Market Trends
        8.4.2    Market Forecast
9    Market Breakup by Distribution Channel
    9.1    Retail Pharmacies
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Specialty Pharmacies
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Hospital Pharmacies
        9.3.1    Market Trends
        9.3.2    Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1    Market Overview
        10.1.2    Market Performance
        10.1.3    Market Breakup by Country
        10.1.4    United States
            10.1.4.1    Market Trends
            10.1.4.2    Market Forecast
        10.1.5    Canada
            10.1.5.1    Market Trends
            10.1.5.2    Market Forecast
    10.2    Europe
        10.2.1    Market Overview
        10.2.2    Market Performance
        10.2.3    Market Breakup by Country
        10.2.4    Italy
            10.2.4.1    Market Trends
            10.2.4.2    Market Forecast
        10.2.5    Germany
            10.2.5.1    Market Trends
            10.2.5.2    Market Forecast
        10.2.6    France
            10.2.6.1    Market Trends
            10.2.6.2    Market Forecast
        10.2.7    United Kingdom
            10.2.7.1    Market Trends
            10.2.7.2    Market Forecast
        10.2.8    Spain
            10.2.8.1    Market Trends
            10.2.8.2    Market Forecast
    10.3    Asia Pacific
        10.3.1    Market Overview
        10.3.2    Market Performance
        10.3.3    Market Breakup by Country
        10.3.4    Japan
            10.3.4.1    Market Trends
            10.3.4.2    Market Forecast
        10.3.5    China
            10.3.5.1    Market Trends
            10.3.5.2    Market Forecast
        10.3.6    India
            10.3.6.1    Market Trends
            10.3.6.2    Market Forecast
        10.3.7    South Korea
            10.3.7.1    Market Trends
            10.3.7.2    Market Forecast
    10.4    Latin America
        10.4.1    Market Overview
        10.4.2    Market Performance
        10.4.3    Market Breakup by Country
        10.4.4    Brazil
            10.4.4.1    Market Trends
            10.4.4.2    Market Forecast
        10.4.5    Mexico
            10.4.5.1    Market Trends
            10.4.5.2    Market Forecast
    10.5    Middle East and Africa
        10.5.1    Market Overview
        10.5.2    Market Performance
        10.5.3    Market Forecast
11    Competitive Landscape
    11.1    Market Structure
    11.2    Key Players
    11.3    Profiles of Key Players
        11.3.1    Teva Pharmaceuticals Industries
        11.3.2    Akorn, Inc.
        11.3.3    Mylan N.V.
        11.3.4    Mallinckrodt
        11.3.5    Sandoz International GmbH
        11.3.6    Pfizer, Inc.
        11.3.7    Sun Pharmaceutical Industries Ltd.
        11.3.8    Valeant Pharmaceuticals
        11.3.9    Apotex Corp.
        11.3.10    Endo International plc. 

 
List of Figures

Figure 1: Global: Specialty Generics Market: Sales Value (in Billion US$), 2013-2018
Figure 2: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2018
Figure 3: Global: Specialty Generics Market: Breakup by Indication (in %), 2018
Figure 4: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2018
Figure 5: Global: Specialty Generics Market: Breakup by Region (in %), 2018
Figure 6: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2019-2024
Figure 7: Global: Specialty Generics Industry: SWOT Analysis
Figure 8: Global: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 9: Global: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2013 & 2018
Figure 10: Global: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2019-2024
Figure 11: Global: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2013 & 2018
Figure 12: Global: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2019-2024
Figure 13: Global: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2013 & 2018
Figure 14: Global: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2019-2024
Figure 15: Global: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2013 & 2018
Figure 16: Global: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2019-2024
Figure 17: Global: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2013 & 2018
Figure 18: Global: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2019-2024
Figure 19: Global: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2013 & 2018
Figure 20: Global: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2019-2024
Figure 21: Global: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2013 & 2018
Figure 22: Global: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2019-2024
Figure 23: Global: Specialty Generics Market: Sales Through Retail Pharmacies (in Billion US$), 2013 & 2018
Figure 24: Global: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Billion US$), 2019-2024
Figure 25: Global: Specialty Generics Market: Sales Through Specialty Pharmacies (in Billion US$), 2013 & 2018
Figure 26: Global: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Billion US$), 2019-2024
Figure 27: Global: Specialty Generics Market: Sales Through Hospital Pharmacies (in Billion US$), 2013 & 2018
Figure 28: Global: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Billion US$), 2019-2024
Figure 29: North America: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 30: North America: Specialty Generics Market: Breakup by Country (in %), 2018
Figure 31: United States: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 32: United States: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 33: Canada: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 34: Canada: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 35: Europe: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 36: Europe: Specialty Generics Market: Breakup by Country (in %), 2018
Figure 37: Italy: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 38: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 39: Germany: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 40: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 41: France: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 42: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 43: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 44: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 45: Spain: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 46: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 47: Asia Pacific: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 48: Asia Pacific: Specialty Generics Market: Breakup by Country (in %), 2018
Figure 49: Japan: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 50: Japan: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 51: China: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 52: China: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 53: India: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 54: India: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 55: South Korea: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 56: South Korea: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 57: Latin America: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 58: Latin America: Specialty Generics Market: Breakup by Country (in %), 2018
Figure 59: Brazil: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 60: Brazil: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 61: Mexico: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 62: Mexico: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 63: Middle East and Africa: Specialty Generics Market: Sales Value (in Million US$), 2013 & 2018
Figure 64: Middle East and Africa: Specialty Generics Market Forecast: Sales Value (in Million US$), 2019-2024

List of Tables

Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2018 and 2024
Table 2: Global: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2019-2024
Table 3: Global: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2019-2024
Table 4: Global: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2019-2024
Table 5: Global: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2019-2024
Table 6: North America: Specialty Generics Market: Key Industry Highlights, 2018 and 2024
Table 7: Europe: Specialty Generics Market: Key Industry Highlights, 2018 and 2024
Table 8: Asia Pacific: Specialty Generics Market: Key Industry Highlights, 2018 and 2024
Table 9: Latin America: Specialty Generics Market: Key Industry Highlights, 2018 and 2024
Table 10: Middle East and Africa: Specialty Generics Market: Key Industry Highlights, 2018 and 2024
Table 11: Global: Specialty Generics Market Structure
Table 12: Global: Specialty Generics Market: Key Players